IGF1R and osteosarcoma: IGF-1R inhibitors should be tested in combination with chemotherapeutic agents, as it has been described that the ligand IGF-2 is upregulated in patients in response to chemotherapy [12] and that in osteosarcoma cell lines IGF-1R inhibition can enhance the effect of doxorubicin and radiotherapy [8].